Rapid Emergence and Spread of Severe Acute Respiratory Syndrome Coronavirus 2 Gamma (P.1) Variant in Haiti

Rapid Emergence and Spread of Severe Acute Respiratory Syndrome Coronavirus 2 Gamma (P.1) Variant in Haiti

Abstract After an initial wave of coronavirus disease 2019 (COVID-19) in Haiti in summer 2020 (primarily lineage B.1), seropositivity for anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) was ~40%. Variant P.1 (gamma) was introduced in February 2021, with an in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical infectious diseases 2022-06, Vol.74 (11), p.2057-2060
Hauptverfasser: Tagliamonte, Massimiliano S, Mavian, Carla, Zainabadi, Kayvan, Cash, Melanie N, Lednicky, John A, Magalis, Brittany Rife, Riva, Alberto, Deschamps, Marie Marcelle, Liautaud, Bernard, Rouzier, Vanessa, Fitzgerald, Daniel W, Pape, Jean William, Morris, J Glenn, Salemi, Marco
Format: Artikel
Sprache:eng
Schlagworte:
Brief Reports
COVID-19
COVID-19 Testing
Haiti - epidemiology
Humans
SARS-CoV-2 - genetics
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract After an initial wave of coronavirus disease 2019 (COVID-19) in Haiti in summer 2020 (primarily lineage B.1), seropositivity for anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) was ~40%. Variant P.1 (gamma) was introduced in February 2021, with an initially limited introduction followed by exponential local dissemination within this unvaccinated population with prior exposure to earlier SARS-CoV-2 lineages.
ISSN:1058-4838
1537-6591
DOI:10.1093/cid/ciab736